What is the appropriate workup and management for an 11‑year‑old girl with a positive deamidated gliadin peptide (DGP) antibody suggesting celiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup and Management for Positive Deamidated Gliadin Peptide Antibody in an 11-Year-Old Girl

This child requires immediate measurement of tissue transglutaminase IgA (tTG-IgA) antibodies with total serum IgA level, and if tTG-IgA is positive, proceed to small bowel biopsy for diagnostic confirmation before initiating any dietary changes. 1

Initial Diagnostic Workup

Complete the Serologic Panel

  • Measure tTG-IgA antibodies with total serum IgA level as the primary diagnostic test, since tTG-IgA has superior sensitivity (90-96%) and specificity (>95%) compared to deamidated gliadin peptide (DGP) antibodies alone 2

  • If total IgA is deficient, measure IgG-based tests (IgG tTG or IgG endomysial antibodies) instead, as IgA-based tests will be falsely negative 3

  • Do not rely on isolated positive DGP antibodies for diagnosis, as research shows an isolated positive DGP with normal tTG has only a 2.5% positive predictive value for celiac disease in children 4

Critical Caveat About DGP Testing

The evidence reveals an important limitation: DGP antibodies have poor specificity (26-79%) and should not be used as a standalone screening test 5, 6. In one multicenter study, 148 children were tTG-negative but DGP-positive, yet only 5% (8/148) actually had villous atrophy on biopsy 5. This means isolated positive DGP results lead to many unnecessary biopsies.

However, there are two specific scenarios where DGP adds value:

  • Children under 2 years of age, where DGP may detect cases missed by tTG alone 7
  • IgA-deficient patients, where IgG DGP can identify celiac disease when IgA-based tests are unreliable 3, 6

Confirmatory Testing

Duodenal Biopsy Indications

  • If tTG-IgA is positive, perform esophagogastroduodenoscopy with duodenal biopsies to confirm diagnosis before establishing dietary changes 3, 1

  • Obtain four oriented biopsies from the second portion of the duodenum plus two oriented biopsies from the bulb for adequate histologic assessment 8

  • European guidelines suggest biopsy may be avoided only in symptomatic children with tTG-IgA titers >10 times the upper limit of normal AND positive endomysial antibodies on a separate blood sample, but this approach is not universally adopted 1

HLA Typing

  • Consider HLA-DQ2/DQ8 testing if serologic results are equivocal or if the patient has already started a gluten-free diet, as negative HLA testing effectively rules out celiac disease 3

Pre-Diagnostic Considerations

Maintain Gluten in Diet

  • The child must remain on a gluten-containing diet (at least three slices of wheat bread daily) until all testing is complete, as gluten avoidance reduces sensitivity of both serology and biopsy 3, 2

  • If the patient has already reduced gluten intake, resume normal gluten consumption for 1-3 months before repeat testing 3

Review Medication History

  • Obtain thorough medication history, particularly for angiotensin II receptor blockers like olmesartan, which can cause villous atrophy mimicking celiac disease 3

Management if Celiac Disease is Confirmed

Immediate Referral and Baseline Testing

  • Refer immediately to a dietitian experienced in both celiac disease and pediatric nutrition for gluten-free diet counseling 1

  • Test for micronutrient deficiencies including iron, folate, vitamin D, and vitamin B12, which are common at diagnosis 1

  • Document baseline growth parameters (height and weight) as these are essential markers of treatment success in children 3, 1

Gluten-Free Diet Implementation

  • Strictly avoid all products containing wheat, barley, and rye proteins for life 1

  • Pure oats may be introduced slowly with careful monitoring for adverse reactions, though they are generally safe for most children with celiac disease 1

Follow-Up Schedule

  • Schedule follow-up visits at 6 months, 12 months, then annually thereafter to monitor adherence and disease activity 1, 8

  • Repeat tTG-IgA antibodies at each visit to assess dietary adherence, though negative serology does not guarantee mucosal healing 8

  • Monitor growth parameters closely at each visit, as satisfactory increases in weight and height are essential markers of successful treatment in children and adolescents 3

  • Routine vitamin and mineral testing is unnecessary in children who attend regular follow-up and grow normally without symptoms 3

Special Consideration for Adolescents

Be aware that this 11-year-old is approaching adolescence, a period when adherence typically declines 3, 8. Teenagers are less satisfied with the impact of celiac disease on their lives and are less adherent to gluten-free diets 3. Children lost to follow-up are more frequently non-adherent and antibody-positive 3. Therefore, establish close follow-up early and provide age-appropriate counseling about the importance of dietary adherence to prevent long-term complications including malabsorption, anemia, and osteoporosis 3.

References

Guideline

Celiac Disease Management in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Screening in High-Risk Individuals

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The anti-deamidated gliadin peptide antibodies unmask celiac disease in small children with chronic diarrhoea.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011

Guideline

Celiac Disease Follow-up: Complementary Measures to a Gluten-Free Diet

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What does a normal deamidated gliadin (IgA) Immunoglobulin A and (IgG) Immunoglobulin G test result indicate for a patient being evaluated for celiac disease?
What is the recommended initial testing for celiac disease, including serologies?
What is the diagnosis and management for a patient with a positive deamidated gliadin antibody (DGP) Immunoglobulin A (IgA) test?
What is the diagnosis and management for a patient with elevated TTG antibody IgA and gliadin antibody IgA?
What is the difference between endomysial antibodies (EMA) and gliadin antibodies in diagnosing celiac disease?
What is the appropriate evaluation and treatment for hematospermia in an otherwise healthy adult male?
How should I evaluate and manage a 22‑year‑old woman with hirsutism, elevated free testosterone, normal total testosterone, and low sex hormone‑binding globulin?
Can an adult with normal renal function safely take enalapril (ACE inhibitor) together with vitamin C?
What is the most likely diagnosis and appropriate management for a 16-year-old female with a one-week history of gait instability (falling to the left), recent vertigo, a viral prodrome one month ago, normal limb cerebellar testing, inability to perform tandem gait, negative Romberg test, and normal laboratory studies?
In a 22‑year‑old woman with hirsutism, elevated free testosterone, normal total testosterone and low sex hormone‑binding globulin, a day‑14 progesterone of 0.2 ng/mL is reported; what does this indicate about ovulation and how should she be managed for polycystic ovary syndrome if she desires pregnancy versus if she does not?
What are the DSM‑5 criteria for insomnia disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.